HealthTech Arkansas and MedAxiom have come together to create HeartX - a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. HeartX, along with its national coalition of participating cardiology practices, has selected the seven startup healthcare companies that are participating in the 2025-2026 cohort.
CardiaCare is pioneering the world's first non-invasive therapy for atrial fibrillation (AFib). Its wearable device delivers proprietary neuromodulation therapy along with artificial intelligence (AI)-powered advanced cardiac rhythm monitoring. This closed-loop therapy approach enables personalized AFib management at home. Early clinical evidence shows exciting promise for reducing both AFib recurrence and severe symptoms while also providing meaningful long-term cardiac monitoring insights.
CathVision's ECGenius system delivers high-fidelity, noise-cancelling cardiac signals to guide ablation decisions. Its PFAnalyzer™ module provides real-time tissue feedback during pulsed field ablation, while the FaST™ mapping algorithm identifies focal AFib drivers. Together, these tools empower clinicians to make data-driven, precise interventions in complex cardiac procedures.
Dopl Technologies democratizes access to diagnostic imaging and interventional procedures in underserved areas. Its Traverse™ telerobotic ultrasound system allows real-time, remote cardiac imaging, while the SonoFlex™ service connects healthcare facilities with on-demand sonographers. Dopl's integrated approach addresses workforce shortages and geographic barriers, improving access and outcomes.
Echopoint Medical's iKOr™ microcatheter system delivers FullPhysiology™ coronary measurements to support more accurate diagnosis and treatment of patients with coronary disease. Seamlessly integrating into existing cath lab workflows, the system provides cardiologists with real-time, actionable insights—enabling more precise and personalized care at the point of treatment.
Fibricheck is a U.S. Food and Drug Administration (FDA)-cleared platform for remote AFib detection and monitoring. Using photoplethysmography (PPG) technology, its validated AI algorithm provides highly accurate heart rhythm assessments. Patients use only their smartphones for seamless, at-home monitoring, while clinicians access a secure provider portal with automated reports and actionable insights. The platform integrates into clinical workflows, supports reimbursement, and supports informed decision-making.
HEARTio is an AI-powered diagnostic platform that analyzes 12-lead ECGs to detect and assess coronary disease. Its seamless API integration delivers rapid, actionable insights directly into the clinical workflow, enabling improved risk stratification, reduced unnecessary testing, and optimized patient management for healthcare providers.
LiveMetric offers an FDA- and CE-Cleared, calibration-free, cuff-free, wearable blood pressure and heart rate monitoring with intensive care unit-grade accuracy. Its LiveOne Band is aimed at providing continuous, non-invasive hemodynamic data to support decision-making across 20+ cardiovascular conditions. The platform empowers clinicians and hospitals with real-time insights, bringing hospital-quality monitoring to patients' everyday lives.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.